DNA damage repair (DDR) related prognostic risk model in multiple myeloma based on single-cell and bulk sequencing

Hongxiu Liu1, Zhihua Li2, Yihua Wang3

  • 1Second Clinical Medical College, Shanxi Medical University, Taiyuan City, China; Department of Hematology, The Second Clinical Medical College of Shanxi Medical University, Shanxi Medical University, Taiyuan, China.

DNA Repair
|June 17, 2025
PubMed

Insights

This study identifies DNA damage repair (DDR) gene expression as a predictor of outcomes in multiple myeloma (MM). A new risk model highlights key DDR genes for potential therapeutic targeting and improved patient stratification.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Genomic instability and rearrangements are hallmarks of multiple myeloma (MM).
  • The precise origins of DNA damage and their influence on MM progression are not fully understood.

Purpose of the Study:

  • To investigate the role of DNA damage repair (DDR) genes in multiple myeloma.
  • To develop a prognostic model based on DDR gene expression for risk stratification and treatment guidance.

Main Methods:

  • Screening of DDR genes using single-cell and bulk RNA sequencing data.
  • Weighted Gene Co-expression Network Analysis (WGCNA) and differential expression analysis.
  • Construction and validation of a prognostic nomogram model.

Main Results:

  • A high DDR expression group was associated with poorer patient outcomes in both training and validation cohorts.
  • DDR-related risk scores demonstrated good predictive performance.
  • Differences in immune infiltration and mutation landscapes were observed between low and high DDR groups.
  • PARP1, PCNA, and RAD23A were identified as key DDR-related genes in MM.

Conclusions:

  • A DDR-related prognostic risk model can aid in risk stratification and inform treatment decisions for MM patients.
  • Key prognostic DDR genes may serve as potential biomarkers and therapeutic targets for multiple myeloma.